Urinary Tract Health: Prevention That Has Evidence Behind It

Urinary tract infections are among the most common bacterial infections in adults, and recurrent infections affect a large share of the women who get one. The market for prevention is correspondingly large. Much of what it sells has thin evidence. A few things hold up. Here is the sorted list.

Strong evidence

Drinking more water, if you drink little. A randomized trial in premenopausal women with recurrent infections who drank less than 1.5 liters a day found that adding 1.5 liters daily cut infections roughly in half over a year. The effect is on people who start out low. Pushing intake above normal in someone already well hydrated has no demonstrated benefit. Urine color is a reasonable guide. See what urine color tells you.

Vaginal estrogen after menopause. Falling estrogen changes the vaginal environment in ways that favor infection causing bacteria. Low dose vaginal estrogen, as a cream, tablet, or ring, reduces recurrent infections substantially in postmenopausal women. It is a prescription and a conversation with a clinician, and it is underused.

Preventive antibiotics for frequent recurrence. For people with three or more infections a year, a low daily dose or a single dose after intercourse reduces recurrence markedly. The cost is resistance and side effects, so it is a last resort rather than a first one, but it works.

Moderate evidence

Cranberry. The subject of decades of mixed studies. The most recent Cochrane review, updated in 2023, concluded that cranberry products probably reduce the risk of symptomatic infection in women with recurrent infections, in children, and in people after certain procedures. The effect is modest. Products vary enormously in the active compound, proanthocyanidins, and most juice contains too little and too much sugar. Capsules standardized to a known proanthocyanidin content are the form that was studied. Cranberry does not treat an existing infection.

Methenamine hippurate. An older prescription drug that releases formaldehyde in acidic urine and suppresses bacteria. A large trial published in 2022 found it comparable to daily preventive antibiotics for reducing recurrence, without driving antibiotic resistance. It is gaining favor as an alternative.

Weak or no evidence

D-mannose. A sugar that in theory blocks bacteria from sticking to the bladder wall. Early small trials looked promising. A larger randomized trial published in 2024 found no benefit over placebo in women with recurrent infections. It is safe and popular. It is not supported.

Probiotics. Trials of oral and vaginal lactobacillus products have been small and inconsistent. Some show a benefit, most do not, and the products studied are not the ones on most shelves. Not harmful. Not proven.

Urinating after sex. Universally recommended, never rigorously tested. The mechanism is plausible. The cost is zero. Do it, and know that the evidence is tradition rather than trial.

Wiping direction, cotton underwear, avoiding baths, avoiding tight clothes. Standard hygiene advice with no trial evidence for or against. None of it hurts. None of it has been shown to prevent infection. Women who get recurrent infections are not doing anything wrong, and telling them to change their hygiene tends to add guilt without reducing infections.

Vitamin C to acidify urine. Urine pH does not drop meaningfully with oral vitamin C at normal doses, and there is no trial showing prevention. High doses also interfere with several urine test strip pads. See urine pH test strips.

Things that raise risk

Worth knowing because some are changeable.

• Spermicide, including on condoms and with diaphragms. It disrupts the normal vaginal bacteria. Switching methods reduces recurrence.
• A new sexual partner or increased frequency.
• Incomplete bladder emptying, from prolapse, an enlarged prostate, or nerve conditions.
• Diabetes, especially with high blood sugar, and treatment with SGLT2 inhibitors, which put sugar into urine.
• Catheter use.
• A family history. Susceptibility has a genetic component.

Testing and prevention together

Home UTI strips have a role here. Someone with recurrent infections who tests at the first symptom can start treatment sooner and can give a clinician a record of when infections cluster. The strips have real limits, particularly a high miss rate on the nitrite pad, which are covered in home UTI test kits.

For anyone with three or more infections in a year, the right move is a visit rather than another prevention product. That number triggers a structured evaluation: a culture during an infection to identify the organism, a check for emptying problems, a look at contraception, and a discussion of estrogen, methenamine, or antibiotic prevention. Those are the interventions with evidence. The rest is mostly hope with a price tag.